All News Top50_Update TOP50

Top 50 Stocks to Buy Now — October 6, 2026 Update: 6 added, 6 dropped

Tradestie's Top 50 Stocks to Buy Now ranking for October 6, 2026: PLTR (Palantir Technologies Inc.) holds the #1 spot. 6 stocks joined the list (ALM, FORM, SIMO, FIGR, AAOI, MTSI) and 6 dropped out.

Here is the October 6, 2026 refresh of Tradestie's Top 50 Stocks to Buy Now — a daily composite ranking of large-cap stocks ($1B+ market cap) scored on earnings growth, revenue growth, relative strength versus the S&P 500, profitability, and quality. Today's scan brings 6 new names and 6 drops, with PLTR (Palantir Technologies Inc.) holding the top spot at a composite score of 96.8.

What Changed

Added to the List

  • ALM — Almonty Industries Inc. Common Shar
  • FORM — FormFactor Inc
  • SIMO — Silicon Motion Technology
  • FIGR — Figure Technology Solutions, Inc. C
  • AAOI — Applied Opt
  • MTSI — MACOM Technology Solutions Holdings

Dropped from the List

  • NTNX — NTNX
  • WDAY — WDAY
  • FTK — FTK
  • TECK — TECK
  • SNPS — SNPS
  • TGTX — TGTX

Biggest Mover

ALAB (Astera Labs, Inc. Common Stock) moved up 19 spots, from #24 to #5.

Other notable moves:

  • CVI: #34 → #49 (−15)
  • LITE: #25 → #12 (+13)
  • BE: #37 → #25 (+12)

Today’s Top 10

RankTickerCompanyScore
1PLTRPalantir Technologies Inc.96.8
2AUGOAura Minerals Inc. Common Shares91.9
3ECOOkeanis Eco Tankers Corp.90.0
4FROFrontline Ltd88.0
5ALABAstera Labs, Inc. Common Stock85.0
6SNDKSandisk Corp84.9
7TERTeradyne Inc84.2
8UROYUranium Royalty Corp83.7
9NVDANVIDIA Corporation83.3
10SMCISuper Micro Computer Inc82.9

See the full ranking with live prices, score breakdowns, and the track record on the Top 50 Stocks to Buy Now page, updated every trading day.


Disclaimer: This ranking is generated algorithmically and is for informational purposes only. It is not investment advice. Past performance does not guarantee future results. Always do your own research before making trading decisions.

Share Post LinkedIn
Tradestie Research

Signal-driven market analysis backed by live scanner hit rates, options positioning, and supply-chain data. Every claim is checked against the numbers before it's published. Browse all analysis →